Cytokinetics | CYTK - Current Liabilities


Cytokinetics reported $142.14M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 356.58M 26.56M Sep/2025
Amgen USD 21.79B 1.32B Sep/2025
Bayer EUR 28.96B 825M Sep/2025
Biogen USD 3.29B 106.3M Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Cytokinetics USD 142.14M 11.08M Sep/2025
Eisai JPY 378.25B 33.36B Sep/2025
Eli Lilly USD 40.14B 1.12B Sep/2025
Exelixis USD 373.78M 37.67M Sep/2025
Geron USD 87.71M 23.43M Sep/2025
Halozyme Therapeutics USD 837.23M 702.95M Sep/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
Ligand Pharmaceuticals USD 30.54M 34.2M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Regeneron Pharmaceuticals USD 4.43B 758.1M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025